AU1793395A - 5,6-dihydro-4H-thieno(3,4-c)pyrrole derivatives, their preparation and their therapeutic application - Google Patents

5,6-dihydro-4H-thieno(3,4-c)pyrrole derivatives, their preparation and their therapeutic application

Info

Publication number
AU1793395A
AU1793395A AU17933/95A AU1793395A AU1793395A AU 1793395 A AU1793395 A AU 1793395A AU 17933/95 A AU17933/95 A AU 17933/95A AU 1793395 A AU1793395 A AU 1793395A AU 1793395 A AU1793395 A AU 1793395A
Authority
AU
Australia
Prior art keywords
thieno
dihydro
preparation
therapeutic application
pyrrole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17933/95A
Inventor
Manuel Bedoya Zurita
Gregorio Del Sol Moreno
Juan Antonio Diaz Martin
Maria Dolores Jimenez Bargueno
Ulpiano Martin Escudero Perez
Magali Romanach Ferrer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of AU1793395A publication Critical patent/AU1793395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU17933/95A 1994-05-10 1995-05-09 5,6-dihydro-4H-thieno(3,4-c)pyrrole derivatives, their preparation and their therapeutic application Abandoned AU1793395A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9405716 1994-05-10
FR9405716A FR2719844B1 (en) 1994-05-10 1994-05-10 5,6-dihydro-4h-thieno [3,4-c] pyrrole derivatives, their preparation and their therapeutic use.

Publications (1)

Publication Number Publication Date
AU1793395A true AU1793395A (en) 1995-11-16

Family

ID=9463059

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17933/95A Abandoned AU1793395A (en) 1994-05-10 1995-05-09 5,6-dihydro-4H-thieno(3,4-c)pyrrole derivatives, their preparation and their therapeutic application

Country Status (17)

Country Link
EP (1) EP0682028A1 (en)
JP (1) JPH0853457A (en)
KR (1) KR950032205A (en)
CN (1) CN1117970A (en)
AU (1) AU1793395A (en)
CA (1) CA2148880A1 (en)
CZ (1) CZ119695A3 (en)
FI (1) FI952250A (en)
FR (1) FR2719844B1 (en)
HU (1) HUT72667A (en)
IL (1) IL113673A0 (en)
NO (1) NO951812L (en)
NZ (1) NZ272090A (en)
PL (1) PL308516A1 (en)
RU (1) RU95107154A (en)
SK (1) SK59795A3 (en)
ZA (1) ZA953749B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19514579A1 (en) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Use of alpha-1-olone agonists for the treatment of urinary incontinence
FR2733750B1 (en) * 1995-05-03 1997-06-13 Synthelabo DERIVATIVES OF GAMMA-OXO-ALPHA- (PHENYLMETHYL) -5,6- DIHYDRO-4H-THIENO (3,4-C) PYRROLE-5-BUTANOIQUE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
WO1999057131A1 (en) 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8529546D0 (en) * 1985-11-30 1986-01-08 Beecham Group Plc Compounds
EP0600973A1 (en) * 1991-08-27 1994-06-15 The Upjohn Company A method for treatment of metabolic disorders and metabolism
EP0599697A1 (en) * 1992-11-24 1994-06-01 Synthelabo Pyrrole derivatives, their preparation and application in therapy

Also Published As

Publication number Publication date
EP0682028A1 (en) 1995-11-15
NO951812L (en) 1995-11-13
PL308516A1 (en) 1995-11-13
CA2148880A1 (en) 1995-11-11
SK59795A3 (en) 1995-12-06
JPH0853457A (en) 1996-02-27
NZ272090A (en) 1996-03-26
KR950032205A (en) 1995-12-20
CN1117970A (en) 1996-03-06
RU95107154A (en) 1997-03-20
HUT72667A (en) 1996-05-28
FI952250A (en) 1995-11-11
ZA953749B (en) 1996-04-02
NO951812D0 (en) 1995-05-09
IL113673A0 (en) 1995-08-31
CZ119695A3 (en) 1995-11-15
FI952250A0 (en) 1995-05-09
FR2719844B1 (en) 1996-06-07
FR2719844A1 (en) 1995-11-17

Similar Documents

Publication Publication Date Title
AU6290998A (en) 4,5,6,7-tetrahydro-thieno{3,2-c}pyridine derivatives, their preparation and use
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
ZA948592B (en) 7H-imidazo[1,2-a]pyrazin-8-one derivatives,and their preparation and use
IL118825A (en) Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use
AU6514196A (en) Heterocyclic compounds, their preparation and use
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
IL116139A0 (en) Pyrrole derivatives their preparation and use
AU6514296A (en) Heterocyclic compounds, their preparation and use
AU4018897A (en) Novel 3,4-diaryloxazolone derivatives, methods of preparation and therapeutic uses thereof
AU7095296A (en) Phosphorylamides, their preparation and use
AU5652096A (en) Azacycloalcane derivatives, their preparation and their applications in therapy
AU1638095A (en) Boronic peptide derivatives, preparation and therapeutic application thereof
AU2141695A (en) Imidazo{1,2-a}pyrazine-4-one derivatives, preparation thereof and drugs containing same
IL108343A0 (en) 9H-imidazo [1,2-a] benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
AU1507992A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapy
AU1314995A (en) Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
AU5183193A (en) Pyrrole derivatives, their preparation and their therapeutic use
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU2405397A (en) Thienopyridine derivatives and their use
AU1793395A (en) 5,6-dihydro-4H-thieno(3,4-c)pyrrole derivatives, their preparation and their therapeutic application
AU4211997A (en) Tricyclic indazole derivatives, preparation and therapeutic application thereof
AU1036097A (en) 5-Naphthalen-1-yl-1,3-dioxane derivatives, their preparation and their therapeutic application